AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2019
Feb 25, 2019
29821_dirs_2019-02-25_e95f2975-0814-4afa-962e-4cc16edc19b4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2019-02-21
Reporting Person: Mahoney Michael F (Director, Chairman, President & CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-21 | Deferred Stock Units | $ | A | 67298.0000 | Acquired | 2023-02-21 | Common Stock (67298.0000) | Direct |
| 2019-02-21 | Stock Option (Right to Buy) | $40.1200 | A | 217917.0000 | Acquired | 2029-02-21 | Common Stock (217917.0000) | Direct |
Footnotes
F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.